Anxiety sensitivity (AS; fear of anxiety-related symptoms) is an established transdiagnostic risk factor for psychiatric disorders and is related to a variety of chronic medical conditions. However, AS has not been established as a risk factor for chronic medical conditions. In this study, we review studies on AS and chronic medical conditions (and symptoms/behaviors related to chronic medical conditions) and propose four pathways through which AS may increase risk of chronic medical conditions: (a) increasing fear of medical condition-specific symptoms, (b) perpetuating avoidance of healthy activities, (c) promoting engagement in unhealthy behaviors, and (d) increasing risk of detrimental pathophysiological and pathomechanical alterations. We also discuss the potential utility of using AS reduction interventions as a means of reducing risk of chronic medical conditions.
| INTRODUCTION
The concept of anxiety sensitivity (AS) was first introduced by Reiss and McNally in 1985 and has gained significant attention within the field of psychology (Asmundson, Wright, & Hadjistavropoulos, 2000; Boswell et al., 2013) . AS describes the fear of anxiety-related symptoms, which are largely sensations of heightened arousal (e.g., chest pain, stomach distress, and racing thoughts; McNally, 2002; Reiss, Peterson, Gursky, & McNally, 1986 ). This fear is based upon the belief that anxiety-related sensations have harmful consequences; for instance, individuals with high AS may fear the sensation of their heart beating quickly because they believe it to be a sign of an impending heart attack (Zinbarg, Barlow, & Brown, 1997) . AS is most commonly measured using the Anxiety Sensitivity Index (ASI; Reiss et al., 1986) , a self-report measure that has been revised over time (e.g., Cox, Taylor, & Enns, 1999; Taylor et al., 2007) and which also taps three lowerorder factors: physical (e.g., fear of a heart attack), social (e.g., fear of embarrassment), and mental incapacitation concerns (e.g., fear of going insane; Zinbarg et al., 1997) . AS is often a key change element in the treatment of pathological anxiety and is widely regarded as a transdiagnostic risk factor for anxiety and related disorders (e.g., Boswell et al., 2013; Naragon-Gainey, 2010) . A major reason AS has been so widely examined is that it has been shown to be malleable using brief therapy interventions (e.g., Olthuis, Watt, Mackinnon, & Stewart, 2014) , making it a promising treatment target.
Although most research on AS has focused on its role in the onset and maintenance of anxiety and related psychiatric disorders, there is increasing research on the connection between AS and chronic medical conditions (for an early review, see Asmundson et al., 2000) . The very nature of AS makes it a topic of interest in research on chronic medical conditions, as many of the sensations feared by individuals with high AS are also symptoms of chronic medical conditions. For instance, the ASI-3 (Taylor et al., 2007) assesses fear of rapid heartbeat, stomach distress, chest pain, and chest tightness, all of which can be symptoms of chronic medical conditions, such as heart disease or irritable bowel syndrome (National Heart, Lung, & Blood Institute, 2014) . Multiple studies have documented associations between AS and chronic pain conditions (e.g., fibromyalgia, arthritis, and migraines), gastrointestinal conditions, asthma, vestibular dysfunction (Avallone, McLeish, Luberto, & Bernstein, 2012; Gros, Antony, McCabe, & Swinson, 2009; Hazlett-Stevens, Craske, Mayer, Chang, & Naliboff, 2003; Ocañez, McHugh, & Otto, 2010; Smitherman, Davis, Walters, Young, & Houle, 2014) , as well as cardiovascular disease (Norman & Lang, 2005; Seldenrijk et al., 2013) , HIV/AIDS (Leyro, Vujanovic, & BonnMiller, 2015) , female sexual dysfunction (Burri, Lachance, & Williams, 2014; Meana & Lykins, 2009) , diabetes (Anderbro et al., 2014) , psoriasis (Dixon et al., 2016) , and post-concussion syndrome (e.g., Broshek, De Marco, & Freeman, 2015) .
Given that AS is related to many different types of chronic medical conditions, it is possible that AS may function as a transdiagnostic risk or maintenance factor for chronic medical conditions in a manner similar to its putative role in various psychiatric disorders. However, it is important to note that the temporal sequencing of the relationship between AS and chronic medical conditions has been largely unexamined and that it is likely bidirectional (Asmundson et al., 2000; Norman & Lang, 2005) ; however, there are a number of ways in which AS may lead to the development, maintenance, and/or exacerbation of chronic medical conditions. The goal of this study was to review and integrate existing studies on the relationship between AS and chronic medical conditions, as well as studies on AS and symptoms/behaviors related to chronic medical conditions, to identify specific pathways through which AS may increase risk of chronic medical conditions among adults. The pathways that we have considered here include fear of condition-specific symptoms, avoidance of healthy activities that increase feared symptoms, engagement in maladaptive behaviors that reduce feared symptoms, and pathophysiological and pathomechanical alterations that may be associated with AS.
Relevant studies for this review were identified using PsycINFO and PubMed, as well as scanning references cited in identified articles to evaluate their relevance to our search criteria. Our search terms included various combinations of "anxiety sensitivity" with terms for chronic medical conditions (e.g., "asthma," "cardiovascular disease," "chronic pain," "fibromyalgia," "gastrointestinal conditions," "vestibular dysfunction," and "diabetes"), chronic medical symptoms (e.g., "pain," "cardiac symptoms," and "respiratory symptoms"), and health behaviors (e.g., "substance use," "smoking," "alcohol use," "eating," "exercise," "sleep," and "medication adherence"). Results from our initial literature review using these terms guided us to conduct additional literature searches including terms for chronic medical condition-specific fears (e.g., "pain catastrophizing" and "fear of pain") and pathophysiological variables (e.g., "blood pressure") to identify other relevant studies. We focused on adult samples but did include a study on adolescents examining the association between AS and blood pressure, given the dearth of research in that area. For some topics (e.g., the relationship between AS and smoking), representative papers were included in the text rather than an exhaustive review. However, studies that were not included in representative sections of the paper are included in a supplemental online table, in which all findings and methodological features of each paper reviewed are summarized. A PRISMA flow diagram has also been included as a supplemental online figure.
| FEAR OF CHRONIC MEDICAL CONDITION-SPECIFIC SYMPTOMS
In their review of AS and chronic health conditions, Asmundson et al. (2000) note that it remains unclear whether AS directly exacerbates chronic health conditions or it does so indirectly by increasing vulnerability to fears of symptoms that are specific to chronic medical conditions (e.g., fear of pain, fear of cardiac symptoms, and fear of respiratory symptoms), which in turn, intensify chronic health conditions. If AS indirectly intensifies chronic medical conditions through condition-specific fears, then the types of chronic medical conditions that individuals with high AS are at the greatest risk of developing should depend upon the types of condition-specific fears that they experience. For instance, an individual with high AS who has developed a fear of breathlessness might be more likely to endorse symptoms of asthma, whereas another individual with high AS who fears pain might be more likely to develop fibromyalgia symptoms. In the context of other physical and environmental risk factors for these chronic medical conditions, AS may exacerbate chronic medical symptoms by promoting the development of such condition-specific fears. Asmundson et al. (2000) argue that AS most likely functions as an indirect rather than a direct risk factor for chronic medical conditions based on studies of individuals with chronic pain conditions, which demonstrate that AS exacerbates chronic pain conditions indirectly through fear of pain-related sensations. In other words, having high AS promotes the development of fear of pain, and this increased fear of pain exacerbates chronic pain symptoms and raises the risk of the development, maintenance, or intensification of chronic pain conditions .
Since the publication of Asmundson et al. (2000) review, there has been an increase in research investigating whether different condition-specific fears play a role in the connection between AS and various types of chronic medical conditions, including, but extending beyond, chronic pain conditions. For the purposes of this review, we have considered any studies that assess attention to, sensitivity to, preoccupation with, and catastrophizing about condition-specific symptoms as measuring condition-specific fears. However, it should be noted that increased sensitivity/attention to symptoms and fear of symptoms are not perfectly overlapping concepts; nevertheless, they are inter-related and AS may be a distal vulnerability factor for both. Taken together, the findings from these studies can help clarify whether AS is related to different types of condition-specific fears among individuals with varying chronic medical conditions and if promoting the development of condition-specific fears is one pathway through which AS may maintain or exacerbate chronic medical conditions. The most common areas of inquiry, which are reviewed and synthesized below, have been an extension of the investigation of the role of fear of pain in the AS-chronic pain relationship and newer lines of research investigating the roles of fear of cardiac symptoms in the AS-heart disease relationship and fear of respiratory symptoms in the AS-respiratory condition relationship.
| Fear of pain
There is substantial evidence that the relationship between AS and chronic pain conditions is affected by fear of pain and closely related cognitive-affective factors, such as pain catastrophizing (i.e., a set of exaggerated, negative cognitive schema activated during or in anticipation of a painful experience), pain sensitivity (i.e., the threshold for detecting and experiencing pain), and pain-related anxiety (Asmundson et al., 2000; Ocañez et al., 2010; Stewart & Asmundson, 2006) . Individuals with chronic pain and high AS exhibit more catastrophic cognition about pain, heightened attention to physical threat-related words, and greater fearful appraisal of pain (Asmundson, Norton, & Veloso, 1999; Stewart & Asmundson, 2006) , as well as difficulty disengaging attention from health, pain, and injury-related cues (Asmundson, Kuperos, & Norton, 1997; Carleton, Asmundson, Collimore, & Ellwanger, 2006) . Importantly, findings from pain induction experiments support the notion that AS increases vigilance to and fear of pain, as opposed to the other way around, suggesting that AS may be a distal vulnerability factor for developing both a specific sensitivity to and fear of pain-related sensations (e.g., Keogh & Birkby, 1999; Vlaeyen & Linton, 2000) .
A study of an attentional bias modification intervention for the treatment of fibromyalgia demonstrates that reducing attention to pain-related words (e.g., ache, agony) not only facilitates remission of chronic pain symptoms but also leads to reductions in AS, again pointing to the association of AS with sensitivity to pain-related cues and chronic pain symptoms (Carleton, Richter, & Asmundson, 2011) . Given this finding, the proposed conceptualization of AS as a distal vulnerability factor to pain vigilance and sensitivity is perhaps complicated by the fact that reductions in vigilance to pain-related cues facilitates reductions in AS. However, it is likely that a bidirectional relationship between AS and other cognitive-affective factors exists such that, while AS initially leads to increased sensitivity to and vigilance of pain, it is then further amplified by increases in these factors over time. Although more work needs to be done to confirm the temporal relationships between these variables, overall, findings from these crosssectional, experimental, and treatment studies suggest that AS is connected to the fear of, sensitivity to, and preoccupation with pain, and this connection to pain-specific fears may explain, in part, how AS exacerbates chronic pain symptoms.
To more definitively explain whether AS indirectly exacerbates chronic pain by increasing risk of the development of fear of pain, empirical studies testing mediational models of the association between AS, fear of pain-related constructs, and chronic pain are needed. However, the only published empirical studies testing such mediational models are cross-sectional in nature, constraining the temporal relationship between AS and pain-related cognition and limiting our ability to make causal statements. For example, Thibodeau, Fetzner, Carleton, Kachur, and Asmundson (2013) found AS to be indirectly associated with chronic pain-related functional impairment (e.g., physical deficits, work/leisure interference) through pain-related anxiety in patients in treatment for chronic low back musculoskeletal pain. In one study of patients with chronic pain related to musculoskeletal injury (Asmundson & Taylor, 1996) and another of patients with recurrent headaches (Norton & Asmundson, 2004) , AS was indirectly associated with pain-related escape and avoidance through fear of pain. However, it should be noted that in one study of patients with both chronic musculoskeletal back pain and PTSD symptoms, although AS significantly predicted fear of pain, which in turn predicted increased pain and pain-related disability, the indirect effect of fear of pain between AS and pain symptoms was not significant (Lopez-Martinez, Ramirez-Maestre, & Esteve, 2014) . Overall, however, the bulk of the existing evidence points to the potential role of AS in increasing chronic pain intensity by way of fear of condition-specific symptoms. These studies for the most part support contemporary theories of chronic pain that present AS as a risk factor that exacerbates chronic pain conditions through pain-specific factors such as increased preoccupation with, sensitivity to, and fear of pain (Vlaeyen & Linton, 2000) .
| Fear of cardiac symptoms
There is emerging evidence that AS may also increase vulnerability for heart disease by increasing fear of and sensitivity to cardiac sensations, most notably heart palpitations and accelerated heart rate. In general, individuals with high AS perceive their heart rate more accurately than individuals with low AS, demonstrating increased attention and sensitivity to their heart rate (Domschke, Stevens, Pfleiderer, & Gerlach, 2010) . Although it may seem adaptive to accurately perceive one's heart rate, this ability seems to stem from an increased preoccupation with cardiac symptoms demonstrated by many individuals with heart disease. For instance, among individuals with atrial fibrillation, AS correlates with increased internal monitoring of heartbeat and heart rate reactivity (Ong et al., 2006) , and this preoccupation mediates the association between AS and atrial fibrillation symptom severity/poor quality of life (Ong et al., 2006) . It is not intuitive to consider fear of or sensitivity to cardiac symptoms as a risk factor for developing heart disease; on the contrary, it seems more logical to think of increased preoccupation with cardiac sensations as a response to having a heart condition. The cross-sectional nature of existing studies on AS, fear of cardiac symptoms, and heart conditions leaves the direction of these associations open to question. Nonetheless, fear of cardiac sensations may increase risk of heart conditions insofar as it drives individuals to reduce or avoid feared cardiac sensations by avoiding healthy activities, such as exercise, or engaging in unhealthy ones, such as drug or alcohol use, which may also serve to dampen physiological arousal, including cardiac sensations. The potential roles of these health behaviors in the AS-chronic medical condition association are discussed more fully below.
| Fear of respiratory symptoms
Although there is limited research on the AS-asthma connection, the association between asthma and panic attacks is well-documented (e.g., Carr, Lehrer, & Hochron, 1995; Goodwin & Eaton, 2003) . Individuals with comorbid panic and asthma tend to experience respiratory symptoms such as dyspnea (i.e., shortness of breath) and hyperventilation as part of both panic and asthma attacks (Favreau, Bacon, Labrecque, & Lavoie, 2014) . Many people with asthma panic in response to asthma symptoms, a process termed illness-specific panic fear (Carr et al., 1995) because it suggests that a fear of asthma symptoms triggers the panic attacks. Carr et al. (1995) studied illness-specific panic fear among adult asthmatics; those with high AS were more likely to panic in response to asthma symptoms, even after controlling for pulmonary functioning and dyspnea frequency. This last point is important because it highlights that asthmatics with high AS do not experience more asthma-related panic simply because they experience greater dyspnea. Instead, it may be their fear of and catastrophic cognition about dyspnea that drive them to panic in response to their asthma symptoms. Carr and colleagues' findings suggest that AS may be associated with increased respiratory-specific fears, such as fear of dyspnea, which may perpetuate panic-related respiratory symptoms and maintain asthma over time. This conclusion is further supported by a recent study conducted by McLeish, Johnson, Avallone, and Zvolensky (2016) , in which undergraduates with asthma completed a straw-breathing task. Those with high AS-physical concerns exhibited greater levels of anxiety and asthma symptoms after straw-breathing, suggesting that they were more physically and emotionally reactive to the asthma-like symptoms induced by the task. This heightened reactivity to respiratory symptoms could exacerbate and/or maintain asthma among individuals with high AS. In support of this theory, AS-physical concerns predict poorer asthma control (e.g., the frequency of symptoms and impairment due to symptoms) among young adults with asthma (McLeish, Zvolensky, & Luberto, 2011) . Additionally, a CBT intervention in part designed to help patients differentiate between asthma and panic symptoms among adults with comorbid asthma and panic disorder led to both significant improvements in asthma control and reductions in panic symptoms (Feldman et al., 2016) , perhaps suggesting that greater understanding of respiratory symptoms may play an important role in the reduction in reactivity to both panic and asthma.
Fear of dyspnea may also play a role in the connection between AS and other types of respiratory diseases, such as chronic obstructive pulmonary disease (COPD; Solomon et al., 2014) . AS is related to subjective dyspnea severity among patients referred for pulmonary function tests (Simon et al., 2006) , suggesting that fear of dyspnea may also strengthen the connection between AS and perceived symptoms of pulmonary dysfunction. More specifically, individuals with COPD who have high AS may be more fearful of the respiratory symptoms that go along with this condition. Panic symptoms are also prevalent among COPD patients (e.g., Willgoss & Yohannes, 2013) , and both catastrophic interpretations of shortness of breath and higher AS have been shown to be significant predictors of panic symptoms among individuals with COPD (Giardino et al., 2010; Livermore, Sharpe, & Mckenzie, 2012) . Additionally, among patients with COPD, AS is associated with increased catastrophizing about breathlessness, which, in turn, is associated with decreased respiratory function (Solomon et al., 2014) . Taken together, these findings suggest that AS plays a role in increased panic or fear in response to respiratory symptoms as well as decreased respiratory function. These initial studies also suggest that the "type" of AS that individuals with COPD experience may be centered upon respiratory-related concerns (i.e., shortness of breath) and that this may exacerbate their COPD. In part, this exacerbation may occur because a fear of respiratory symptoms leads to avoidance of physical activity that may cause respiratory-like symptoms such as shortness of breath, but that ultimately could improve lung functioning among individuals with COPD.
| Fear of gastrointestinal symptoms
Although not as widely studied, there are other chronic illnesses in which the association between AS and fears of condition-specific symptoms may play an important role. For instance, research indicates that AS is associated with increased irritable bowel syndrome (IBS) symptomatology (e.g., Gros et al., 2009; Hazlett-Stevens et al., 2003) and that this may be due to its association with fears and/or cognition related to gastrointestinal symptoms. One study found that, among individuals with panic disorder and IBS, AS was associated with cognition related to lower controllability of abdominal symptoms (Sugaya et al., 2013) . A few studies have also examined the association between IBS symptoms and "visceral sensitivity," or fear of stomach and bowel sensations and found this fear to be related to more severe gastrointestinal symptoms (Hunt, Milonova, & Moshier, 2009 ) and predictive of IBS diagnostic status (Hazlett-Stevens et al., 2003) . The potential association between AS and fear of gastrointestinal symptoms may increase risk of the exacerbation of chronic conditions such as IBS by maintaining a cycle of avoidance and increased anxiety related to visceral cues, similar to the ways in which fear of respiratory symptoms may maintain panic and asthma. AS may play a role in fears of gastrointestinal cues in other, related, chronic conditions including Crohn's disease and ulcerative colitis; however, no research to date has examined these AS associations.
| Summary
There is growing evidence that AS increases risk of or maintains chronic medical conditions by promoting the development of condition-specific fears, which vary depending on the medical condition in question. The fact that individuals with high AS also tend to exhibit increased sensitivity to and preoccupation with condition-specific symptoms suggests that the more general vulnerability factor of AS may lead to the development of conditionspecific fears, which then exacerbate medical conditions by keeping individuals fearful of their symptoms and preventing them from engaging in activities that might improve their health. This conclusion is speculative at this point because the supporting studies are largely cross-sectional in nature. Although the association between AS, conditionspecific fears, and chronic medical conditions has been increasingly well documented, longitudinal studies are needed to clarify the temporal sequencing of these variables. It is especially important to clarify if condition-specific fears mediate the association between AS and chronic medical conditions, or if they develop as a reaction to experiencing chronic medical symptoms. Studies examining the association between AS and a broader range of condition-specific fears potentially related to chronic medical conditions are also needed. For instance, there is one published study on adults with type 1 diabetes demonstrating that AS is associated with fear of hypoglycemia, which is associated with poorer health outcomes (Anderbro et al., 2014) . Additionally, AS is associated with increased somatization (Gonzalez, Zvolensky, Solomon, & Miller, 2010) and a range of bodily oriented fears (Gonzalez, Zvolensky, Grover, & Parent, 2012) among individuals with HIV/ AIDS. More research is needed to shed light on whether these fears are condition-specific, as well as how fears related to HIV could serve to exacerbate the illness by the mechanisms mentioned above. More studies focusing on less examined chronic medical conditions, like diabetes and HIV/AIDS, are needed to clarify whether condition-specific fears mediate the association between AS and a wide variety of chronic medical conditions.
| AVOIDANCE OF HEALTHY ACTIVITIES
It is difficult to discuss the impact of AS on the maintenance and exacerbation of chronic medical conditions without considering the role of avoidance, which plays a large role in linking the fear of somatic sensations to disability and impairment. Fear of somatic sensations often leads individuals to avoid activities that might elicit feared sensations, which increases their risk of the development, maintenance, and exacerbation of chronic medical conditions by limiting their behavior in unhealthy ways. Thus, leading theoretical models of chronic pain conditions are termed fear-avoidance models (Vlaeyen & Linton, 2000 , 2012 ; these models emphasize that individuals who have a fearful response to pain are often caught in a vicious cycle of fear of pain and avoidance of activities that could cause them pain. Avoidance of such activities prevents habituation to pain sensations, which maintains the fear of pain over time, further restricts activities, and limits overall functioning. This cycle of fear and avoidance leads to greater chronic pain and disability over time. Although fear-avoidance models have received the greatest attention and empirical support in reference to chronic pain conditions, there is some evidence that these models may also apply to other chronic conditions, such as tinnitus (Hesser & Andersson, 2009 ), IBS (Dindo & Lackner, 2017) , and sexual pain disorders (Cherner & Reissing, 2013) . Individuals with high AS are at increased risk of getting caught in the fear-avoidance cycle because they are more likely to avoid activities that elicit feared sensations. Avoidance of activities that are expected to elicit feared sensations can increase risk of chronic medical conditions and maintain existing ones, because, paradoxically, engaging in many of these activities would actually lead to improved health, potentially preventing or relieving chronic illness over time. Below, we review literature examining the connection between AS and avoidance of healthy activities and consider the possible role that avoidance of healthy activities might play in the AS-chronic medical condition relationship.
| Physical activity and exercise
Despite its health benefits, exercise is avoided by many people to some degree, and individuals with high AS are especially likely to do so. Cross-sectional, laboratory-based, and naturalistic studies show that AS is associated with increased distress during exercise and decreased engagement in exercise (e.g., Hearon, Quatromoni, Mascoop, & Otto, 2014; McWilliams & Asmundson, 2001; Smits, Tart, Presnell, Rosenfield, & Otto, 2010) . Physically inactive adults also score significantly higher on the physical and mental incapacitation subscales of the ASI compared with physically active adults (Smits & Zvolensky, 2006) . Individuals with high AS may avoid exercise because it induces physiological arousal, which may be accompanied by many feared physical sensations, such as increased heart rate and shortness of breath, and may also trigger feared psychological symptoms, such as feeling like one's mind is racing or feeling "spacey." Individuals with high AS who also have a high body mass index (BMI) are especially likely to experience fear while exercising (Smits et al., 2010) and avoid daily exercise (Hearon et al., 2014) . Exercise elicits more aversive sensations for individuals with high BMI, and this discomfort may be harder to tolerate for those also high in AS (Smits et al., 2010) . Decreased exercise among individuals with high AS could also be related to the association of AS with the more general experience of somatic symptoms; for instance, among obese individuals, high AS predicts increased somatic symptom severity (Fergus, Limbers, Griggs, & Kelley, 2017) , and severe somatic symptoms are often associated with decreased physical activity (Hoerster et al., 2015) . Whether AS directly or indirectly impacts aversion to physical activity, by avoiding exercise, individuals with high AS may place themselves at elevated risk of developing or continuing to suffer from chronic medical conditions.
| Daily activities
In addition to increasing avoidance of activities that elicit feared sensations or are connected to specific fears, AS may increase avoidance of more general, daily activities among individuals with chronic medical conditions. Patients with chronic medical conditions often avoid activities such as work and social engagements as a maladaptive way of coping with their medical symptoms (Duangdao & Roesch, 2008; Rozema, V€ ollink, & Lechner, 2009) . Those with high AS may be especially likely to avoid daily activities due to fears of experiencing unpleasant sensations. Norton and Asmundson (2004) found that, among patients with chronic headaches, AS was indirectly associated with higher scores on a pain-related avoidance scale, which was comprised of statements such as "when I feel pain I try to stay as still as possible" and "I try to avoid activities which cause pain." AS seems to be associated not only with avoidance of pain-related activities, but also with a propensity to disengage from more general activities when chronic pain persists (Esteve, Ram ırez-Maestre, & L opez-Mart ınez, 2011). A similar phenomenon has been demonstrated among individuals with tinnitus (Hesser & Andersson, 2009 ) and may occur among individuals with other conditions as well. Future research is necessary to determine whether AS increases risk of widespread reductions in activity among individuals with a variety of chronic medical conditions as it seems to do for those with chronic pain. If this is the case, it may be important to work with individuals with high AS on staying generally active even when they are experiencing chronic medical symptoms such as pain or fatigue, as avoidance is a maladaptive strategy for coping with chronic medical symptoms that exacerbates illness severity and leads to decreased functioning and greater impairment.
| Medication adherence
Another reason that individuals with high AS are more likely to have chronic medical conditions may be that they tend to have poor medication adherence. Many medications prescribed for chronic medical conditions have side effects that involve sensations typically feared by those with high AS. For example, gastrointestinal disturbance is a common side effect of antiretroviral therapy (ART) for HIV (Hawkins, 2010) , and blood pressure medications that are often used to prevent and treat cardiovascular disease can result in dizziness and heart palpitations (Marshall, Wolfe, & McKevitt, 2012) . Individuals with high AS may be especially sensitive to and fearful of medication side effects, which may cause them to avoid taking prescribed medications, thus exacerbating their risk of chronic medical conditions. They may also be more likely to avoid any and all reminders of their medical risk factors or chronic health conditions, such as medications, which could also negatively impact medication adherence.
Despite the theoretical connection between increased AS and decreased medication adherence, only a few studies have examined this connection among individuals either with or at risk of chronic medical conditions, and they have resulted in mixed findings. In a sample of patients with uncontrolled hypertension, almost twice as many patients with high AS were nonadherent to their medication regimen in comparison with those with low AS, and patients with high AS were more likely to report experiencing side effects from their blood pressure medications (Alc antara et al., 2014) . Further, higher AS was associated with lower medication adherence, even after controlling for state anxiety. Individuals with high AS appear to be more sensitive to blood pressure medication side effects, which may lead them to avoid taking such medications, increasing their risk of cardiovascular disease. On the other hand, a study of patients with COPD found that AS did not significantly differ between patients who adhered to proper inhaler use versus those who did not (Turan, Yemez, & Itil, 2014 ). Yet another study on medication adherence among individuals with HIV did not find a significant connection between AS and adherence to ART (Leyro et al., 2015) . There is some evidence that individuals with HIV who have high AS engage in greater illicit substance use, which in turn negatively affects their medication adherence (Gonzalez, Barinas, & O'Cleirigh, 2011), but AS does not seem to be directly related to decreased medication adherence among patients with HIV in the way that it is among patients with hypertension. Due to the lack of research on AS and medication adherence, it is unclear if these studies have discrepant findings because they focus on different medical conditions and medications with distinct side effects. Additionally, the study on HIV did not examine the impact of AS on sensitivity to ART side effects, which may be an important variable to consider. Further research examining the connection between AS and medication adherence among individuals with chronic medical conditions is necessary to clarify whether there is evidence to support the conclusion that AS increases risk of poor medication adherence. In addition, understanding the role of AS in the relationship between stigma and adherence to medical treatment may be another important avenue of research, particularly among individuals with HIV/AIDS and other stigmatized illnesses. A recent study found that AS mediated the association between HIV-related stigma and increased HIV symptom severity (Brandt, Paulus, Jardin, et al., 2017) ; however, the mechanism through which AS is associated with symptom severity is not yet clear. One potential area for future research would be to examine whether AS in the context of stigma contributes to decreased engagement in health behaviors, especially behaviors like medication adherence that may be associated with public displays of illness.
| Preventive dental/medical treatment
AS is associated with avoidance of preventive dental care, which can lead to poor oral health and increased risk of the development and maintenance of chronic medical conditions that are associated with oral disease, such as cardiovascular disease (Weiner, 2013) . AS is associated with the presence of dental phobia (Kılıc ß, Ak, & Ak, 2014), and dental phobic individuals tend to visit the dentist less than once a year, which is below the clinical recommendation for adequate preventive dental care (van Houtem et al., 2014) . Individuals with high AS may avoid dental care because they fear the possibility of experiencing anxiety-related sensations or other types of unpleasant somatic sensations, such as pain, during dental procedures. Indeed, among adults with high dental anxiety, those with high AS have greater expectations of experiencing pain during dental treatment and experience greater levels of self-reported pain during dental treatment (Klages, Kianifard, Ulusoy, & Wehrbein, 2006) . Individuals with high AS may also be more likely to feel out of control during dental procedures and worry about oral health issues being discovered during routine dental care, and both of these concerns could lead to decreased utilization of preventive dental care (Weiner, 2013) . By avoiding dental care, individuals with high AS place themselves at greater risk of experiencing oral health problems such as tooth decay and gingivitis that increase risk of longer-term chronic medical issues (Harokopakis, Albzreh, Martin, & Hajshengallis, 2006) . A similar process may foster a connection between AS and avoidance of preventive medical care, but to our knowledge, no published empirical studies have examined this. Further studies on the connection between AS and avoidance of dental/medical care are needed to clarify if AS exacerbates chronic medical conditions by promoting avoidance of preventive physical health care.
| Summary
There is a great deal of evidence that avoidance of healthy activities is a maintenance factor for a variety of chronic medical conditions, but less research has examined the role that AS may play in increasing avoidance of healthy activities and, in turn, exacerbating chronic illness. AS is associated with greater avoidance of and interference with specific behaviors that are important for maintaining physical health, such as exercise, medication adherence, and use of preventive dental care, which may lead to greater risk of developing chronic medical conditions. Further studies examining whether avoidance of these healthy behaviors mediates the relationship between AS and chronic medical conditions are necessary to draw firmer conclusions. In addition to focusing on specific healthy behaviors, further studies examining the association between AS and restrictions in general, daily activities among individuals with a wide range of chronic medical conditions are necessary. Whereas avoidance of exercise and dental/medical care may place individuals with high AS at greater risk of developing chronic illness, after the onset of chronic illness, avoidance of daily activities may maintain illness among high AS individuals, who seem to be more likely to cope with chronic medical symptoms by reducing their general activity levels.
| ENGAGEMENT IN

MALADAPTIVE HEALTH BEHAVIORS
In addition to promoting avoidance of healthy activities, AS may also drive individuals to engage in behaviors that are detrimental to their physical health (Otto et al., 2016) . Individuals with high AS may engage in maladaptive health behaviors, such as heavy drinking, to avoid experiencing feared symptoms and sensations. In this way, unhealthy behaviors may have an experientially avoidant function, because they protect individuals with high AS from unpleasant or unwanted experiences (Forsyth, Parker, & Finlay, 2003; Stewart, Zvolensky, & Eifert, 2002) . Experiential avoidance, defined as the avoidance of contact with unwanted internal experiences -including thoughts, emotions, and physical sensations -may function as a means not only to avoid conditionspecific symptoms among individuals with high AS, but also to avoid negative mood states such as anxiety and depression and the sensations associated with them. Motivation to avoid negative affect is one of the strongest drivers of maladaptive drug use (e.g., Baker, Piper, McCarthy, Majeskie, & Fiore, 2004) , and AS may exacerbate this drive. For instance, AS is a well-established moderator of the link between anxiety disorders and drug use (Morissette, Tull, Gulliver, Kamholz, & Zimering, 2007) , suggesting that the avoidance of negative mood states is an important pathway through which AS may contribute to substance use, in addition to the avoidance of unwanted and condition-specific symptoms.
By reducing feared or unwanted symptoms and sensations, maladaptive health behaviors are negatively reinforced for individuals with high AS, which may foster the development of unhealthy lifestyles that increase risk of chronic medical conditions. Many of the maladaptive health behaviors that are associated with high AS, such as substance use and unhealthy eating, are established risk factors for serious chronic diseases such as heart disease and cancer (National Heart, Lung, & Blood Institute, 2014); additionally, maladaptive behaviors such as substance use, and in particular injection use, are also associated with increased risk of transmission of chronic diseases such as HIV and Hepatitis C (e.g., Purcell, Parsons, Halkitis, Mizuno, & Woods, 2001 ). McNally (1996) suggested that AS may be differentially associated with specific types of substance use. He theorized that AS may be positively associated with use of substances that reduce arousal (e.g., alcohol, anxiolytics, and analgesics), but negatively associated with use of substances that increase arousal (e.g., caffeine, cocaine, and amphetamines). He reasoned that individuals with high AS avoid physiological arousal because they fear arousalrelated sensations, so they should be drawn to substances that dampen arousal but put off by substances that increase arousal. Although conceptually sound, McNally's hypothesis has received mixed support from empirical studies. There is considerable evidence in support of the first part of his hypothesis that AS is positively associated with use of anxiolytic and arousal-dampening substances. A number of studies on undergraduate, community, and clinical samples have shown that AS is associated with greater consumption of alcohol and/or more problems with alcohol use (e.g., Chavarria et al., 2015; Howell, Leyro, Hogan, Buckner, & Zvolensky, 2010; Woicik, Stewart, Pihl, & Conrod, 2009) . Two cross-sectional studies examining the link between AS and alcohol-related outcomes among adult smokers and people living with HIV/AIDS, respectively, found that difficulties with emotion regulation mediated the relationship between AS and hazardous drinking (Paulus, Jardin, et al., 2016; Paulus et al., 2017) , suggesting the potential additional role of maladaptive regulation of negative affect in the link between AS and alcohol use in these medical populations. There is also some evidence of a link between AS and increased cannabis use (Paulus, Manning, Hogan, & Zvolensky, 2016) and increased coping and conformity motives for use (Bonn-Miller, Zvolensky, & Bernstein, 2007; Zvolensky, Marshall, et al., 2009) , although a recent cross-sectional study found that lower distress tolerance was associated with increased cannabis dependence symptoms and stronger coping motives, whereas AS was not (Farris, Metrik, Bonn-Miller, Kahler, & Zvolensky, 2016) . Further, individuals with high AS demonstrate a propensity to use alcohol and tobacco specifically to cope with distress (e.g., Brown, Kahler, Zvolensky, Lejuez, & Ramsey, 2001; Woicik et al., 2009) , again suggesting that tension reduction is a primary motivation for their substance use, as McNally (1996) suggested.
| Substance use
There is also evidence that AS is associated with the use of other types of anxiolytic and sedating drugs. Among both undergraduates with a history of illicit drug use and opioid-dependent patients, AS is positively associated with frequency of sedative drug use (Hearon et al., 2011; Woicik et al., 2009) . AS may even play a role in the development of dependence on sedatives, such as benzodiazepines. For instance, older primary care patients with high AS are more resistant to cutting back on benzodiazepine use (Cook, Biyanova, Masci, & Coyne, 2007) . Taken together, studies on AS and use of sedatives show a strong pattern of support for McNally's (1996) hypothesis that individuals with high AS are more likely to use substances that reduce arousal. The tension reduction that individuals with high AS experience from sedative use may place them at risk of misusing sedatives and experiencing physical health consequences as a result.
The limited empirical studies of the second part of McNally's (1996) hypothesis, that individuals with high AS may avoid substances that induce physiological arousal, have generated mixed findings. Some studies have found that, as McNally predicted, individuals with high AS who use drugs show a greater preference for sedating drugs and tend to stay away from drugs that increase physiological arousal, such as cocaine (Lejuez, Paulson, Daughters, Bornovalova, & Zvolensky, 2006; Norton, Rockman, Ediger, & Pepe, 1997) . On the other hand, Buckner, Proctor, Reynolds, Kopetz, and Lejuez (2011) examined the association between AS and cocaine dependence among 304 patients of a substance use residential treatment facility and found that patients with high AS were more likely to meet criteria for a diagnosis of cocaine dependence. Other findings have indicated that AS is positively associated with caffeine consumption in males (McWilliams & Asmundson, 2001 ). It is possible that, in contrast to McNally's hypothesis, individuals with high AS are at increased risk of using both arousal-dampening and arousal-inducing substances. Buckner et al. (2011) suggested that individuals with high AS may be drawn to substances like cocaine because they promote positive affect and may reduce distress associated with anxious arousal, even though they do not reduce (and may even increase) the arousal itself. The same may be true of caffeine, which could be attractive due to its promotion of positive affect and sensations of clear thinking. Once they have become dependent on arousal-inducing substances, individuals with AS may also struggle with reducing their use because they experience intense symptoms of withdrawal (e.g., Johnson, Stewart, Rosenfield, Steeves, & Zvolensky, 2012) . Additional studies examining the nature and course of use of arousal-inducing substances among individuals with high AS are needed to better clarify whether this type of substance use is problematic for them and if it increases their risk of chronic diseases.
| Smoking behavior
Smoking behavior has strong associations with AS, and more difficult withdrawal from nicotine is consistently associated with higher AS. For example, smokers with high AS experience more intense withdrawal symptoms during quit attempts (Johnson et al., 2012; Langdon et al., 2013) and are at greater risk of poor smoking cessation outcomes (Zvolensky, Stewart, Vujanovic, Gavric, & Steeves, 2009 ). Smoking behaviors are also strongly associated with motivation to cope with distress (Brown et al., 2001 ) and reduce negative affect (Leyro, Zvolensky, Vujanovic, & Bernstein, 2008; Zvolensky et al., 2006) among individuals with high AS (Guillot, Leventhal, Raines, Zvolensky, & Schmidt, 2016) . AS also mediates the association between both anxious arousal and PTSD symptoms and expectancies about the harmful consequences of and somatic symptoms associated with smoking abstinence (Farris, Paulus, et al., 2015; , suggesting that AS plays a role not only in the association between negative affect and smoking behaviors, but also in the association between negative affect and difficulties with quitting.
Importantly, AS-smoking associations may have implications for the maintenance or exacerbation of related respiratory conditions. Smoking is more common among individuals with asthma than those without (e.g., Frank, Morris, Hazell, Linehan, & Frank, 2006) , and AS may play an important role in this association. For instance, in a sample of trauma-exposed smokers, AS significantly predicted respiratory symptoms above and beyond PTSD symptoms (Mahaffey et al., 2017) . Other studies have found that smokers with asthma report higher levels of AS than smokers without asthma (Johnson & McLeish, 2017) and that, when comparing smokers and non-smokers both with and without asthma, there is a significant indirect effect of asthma diagnosis on smoking via AS . Although cross-sectional in nature, these studies suggest that AS does play an important role in the relationship between respiratory symptoms and smoking, despite limits in our current understanding of the temporal sequencing of these associations. AS is also associated with barriers to smoking cessation among individuals with respiratory illness (McLeish et al., 2016) . Asthma status is indirectly related to both stronger motives for quitting and stronger motives for nicotine use and dependence through AS (McLeish, Farris, Johnson, Bernstein, & Zvolensky, 2015) , a finding that supports the notion that, for individuals with respiratory illness, AS is associated with a greater desire to quit smoking but more difficulty doing so once dependency is established. Furthermore, greater respiratory symptoms have been shown to be a significant predictor of early lapses in smoking cessation among those with high, but not low, levels of AS (Zvolensky, Rodr ıguez-Cano, et al., 2017) . This finding again suggests that AS is an important mechanism in continued engagement in maladaptive substance use among individuals with respiratory illness.
The link between AS and smoking behaviors may have important implications for other chronic illnesses in addition to respiratory illnesses. For instance, about 70% of HIV/AIDS outpatients report daily smoking (Niaura et al., 2000) , and smoking status among individuals with HIV/ AIDS moderated the predictive influence of AS on other maladaptive health behaviors including hazardous drinking and sexual compulsivity (Brandt, Bakhshaie, et al., 2017) , a finding that may indicate that individuals with HIV who smoke are particularly at risk of adverse AS-health outcome associations. However, more work is needed in this area not only to establish the role of AS in the association between smoking and HIV/AIDS, but also to further establish how this link may, in turn, increase risk of the exacerbation of the illness via other maladaptive health behaviors such as hazardous drinking. Overall, the association between AS and smoking is likely an important area of study within the context of a wide range of chronic illnesses, and further examination of how distinct illnesses may be negatively affected by AS-smoking behavior associations is warranted.
| Sleep disturbance
Many individuals with chronic medical conditions suffer from sleep disturbance, and disturbed sleep is associated with poorer medical outcomes. For instance, up to 73% of individuals with HIV report significant sleep disturbance, which is associated with decreased adherence to ART, increased viral load, and greater HIV symptom severity (Babson, Heinz, & Bonn-Miller, 2013; Saberi, Neilands, & Johnson, 2011) . AS may increase risk of chronic medical conditions by contributing to sleep disturbance. Among individuals with HIV, for instance, those with higher AS report poorer sleep quality compared to those with lower AS (Bakhshaie et al., 2018; Leyro, Babson, & BonnMiller, 2014) . Other studies also demonstrate that individuals with high AS have greater difficulty falling and staying asleep and report decreased sleep quality (e.g., Baker et al., 2017) . Some have found that AS is not directly associated with sleep disturbance but is associated with greater sleeprelated impairment (e.g., increased fatigue, interference with work/chores; Vincent & Walker, 2001) . These studies show a connection between AS and sleep dysfunction; however, it remains unclear if AS plays a causal role in the development of sleep dysfunction.
There are a number of reasons why AS may contribute to the development of sleep dysfunction. Individuals with high AS may be more sensitive to internal cues associated with sleep, such as sensations of fatigue, and more likely to catastrophize about the meaning of such cues. Sensitivity to sleep-related internal cues may lead individuals with high AS to develop anxiety about sleep, thereby increasing their anxious arousal when they are trying to go to sleep and making it harder for them to achieve restful, satisfying sleep (Harvey, 2002) . Indeed, AS strengthens the association between anticipatory anxiety about sleep and sleep disturbance (Babson, Trainor, Bunaciu, & Feldner, 2008) . AS may also increase risk of developing dysfunctional beliefs about sleep (e.g., believing that there are severe consequences to inadequate sleep) that are associated with sleep problems like insomnia. Among a sample of individuals with emotional disorders, AS was not related to insomnia severity, but it was related to dysfunctional beliefs about sleep (Fairholme, Carl, Farchione, & Schonwetter, 2012) . Further, AS strengthened the effect of dysfunctional beliefs on insomnia severity. Taken together, these findings suggest that AS may increase sleep disturbance by serving as a cognitive-affective risk factor for more specific key processes that underlie sleep dysfunction, such as anticipatory anxiety and dysfunctional beliefs about sleep.
| Unhealthy eating
Individuals with elevated AS also engage in unhealthy eating behaviors, particularly behaviors that involve overeating, such as binge eating and emotional eating (i.e., eating in response to emotional distress). These behaviors can escalate into an eating disorder and/or place individuals with high AS at risk of experiencing obesity-related chronic illnesses, such as heart disease and diabetes (Manson, Skerrett, Greenland, & VanItallie, 2004) . The existing body of published literature on the connection between AS and maladaptive eating is small, but consists of studies including both self-report and behavioral measures of eating as well as both eating disordered and nonclinical samples. Studies using self-report measures show that increased AS is associated with maladaptive eating behaviors among undergraduates, eating disorder outpatients, and obese/overweight adults (e.g., Anestis, HolmDenoma, Gordon, Schmidt, & Joiner, 2008; Hearon, Utschig, Smits, Moshier, & Otto, 2013) . AS mental incapacitation concerns seem to be particularly associated with maladaptive eating (Fulton et al., 2012; Hearon et al., 2013) , suggesting that unhealthy eating behaviors may be more connected to the fear of cognitive dyscontrol than other facets of AS. In a cross-sectional study in a group of undergraduate students, the relationship between AS and disordered eating was mediated by experiential avoidance (Fulton et al., 2012) , a finding that suggests that maladaptive eating may have a similar function as substance use for individuals with high AS; they may turn to both of these unhealthy activities in an effort to avoid experiencing feared sensations.
It is worth noting the seemingly unique link between fear of cognitive dyscontrol and maladaptive eating, which seems unexpected given the importance of gastrointestinal cues in eating behavior. However, a large body of literature supports the notion that, among individuals with maladaptive eating behaviors, particularly binge eating, loss of control is reported to be one of the most salient features of binge episodes (e.g., Telch, Pratt, & Niego, 1998) and is associated with increased distress and impairment over time (e.g., Goldschmidt et al., 2012) . Furthermore, it has been well-established that maladaptive eating behavior is in part motivated by affect regulation (Polivy & Herman, 1993) . Due to the prominence of cognitive and negative affective cues for many individuals engaged in maladaptive eating, it is perhaps not altogether surprising that fears of cognitive dyscontrol are also some of most salient fears for these individuals.
Studies using behavioral measures of eating in both laboratory and naturalistic settings corroborate self-report findings and highlight the avoidance-coping function of eating for individuals with high AS. Hearon et al. (2013) measured consumption of unhealthy snacks following a laboratory-based induction of negative mood among overweight adults. They did not observe a direct association between AS and consumption. Instead, a more complex three-way interaction emerged that, when broken down, demonstrates that AS mental incapacitation concerns and feeling out of control while eating may work together as joint risk factors for unhealthy eating among overweight individuals, but not among normal weight individuals. In a subsequent study, Hearon et al. (2014) had adults monitor their affect and food intake for 3 days and found a similar connection between high AS and eating in response to negative mood, suggesting that their laboratory findings generalize to a more naturalistic setting. As noted above, these findings suggest that AS is associated with increased eating in response to negative mood and high AS individuals may self-medicate negative mood by eating unhealthy foods in a manner similar to how they often use drugs and alcohol.
| Overutilization of symptom-driven medical treatment
Another way in which AS may exacerbate chronic medical conditions is by increasing overutilization of certain types of medical treatment. This may be surprising given the evidence reviewed earlier that AS is associated with avoidance of preventive dental care and possibly with other forms of preventive medical care. Even though AS is associated with decreased use of preventive care, it may be associated with increased use of medical care in response to symptoms. In fact, these two processes may be related; individuals with high AS may avoid preventive medical care, experience greater symptoms as a result, and then seek emergency services once symptoms become intolerable. For instance, Favreau et al. (2014) found that among patients with physiciandiagnosed asthma, AS was associated with higher rates of emergency department (ED) visits. Favreau et al. (2014) note that it is unclear if individuals with high AS generally engage in appropriate use of ED services in response to true medical symptoms or inappropriate use of ED services driven by hypochondriacal concerns.
Health anxiety may be an important additional factor to consider in the relationship between AS and the use of medical treatment, given the strong association between AS and health anxiety (e.g., Deacon & Abramowitz, 2006) as well as the well-established link between health anxiety and inappropriate use of medical services (e.g., Creed, 2011) . AS-health anxiety associations have been observed in both healthy (e.g., Fergus, 2014) and medical (e.g., Jones, Hadjistavropoulos, & Gullickson, 2014) populations, suggesting a link between AS and health anxiety in both the presence and absence of medical symptoms. However, AS has particularly strong associations with health anxiety when coupled with severe, compared to mild, somatic symptoms such as chest pain, stomach pain, and dizziness (Fergus, Kelley, & Griggs, 2016; Fergus et al., 2017) , suggesting that AS may be a vulnerability factor for the experience of health anxiety particularly among individuals with more severe somatic symptoms associated with illness. Due to the association between health anxiety and the use of ED services (e.g., Fergus, Bardeen, Gratz, Fulton, & Tull, 2015) , health anxiety may be an important mechanism in the association between AS and maladaptive health-care use. Overall, it is important for further studies to follow-up on this question to better understand what drives high AS individuals to seek ED services, but regardless, their increased use of ED services may exacerbate chronic medical conditions insofar as it creates a reliance on symptom-driven medical treatment and contributes to avoidance of preventive medical care. ED visits may also serve a reassurance-seeking role for individuals with high AS that contributes to the cycle of avoiding preventive care and overutilizing emergency or symptom-driven care.
AS is also associated with greater use of medications that target chronic medical symptoms. Asmundson and Norton (1995) found greater use of analgesic medications among patients with chronic back pain who had high AS, although in a study on patients with chronic headaches, they did not find a significant association between AS and analgesic use (Asmundson, Norton, & Veloso, 1999) . AS is also associated with greater sleep medication use even when controlling for sleep quality, demonstrating that greater sleep disturbance alone does not fully account for increased frequency of sleep medication use (Babson, Badour, Feldner, & Bown, 2012) . Similarly to the questionable appropriateness of ED visits by high AS individuals, it is difficult to determine whether their medication use is appropriate, although the fact that it does not seem to be accounted for by greater medical symptoms suggests that it may not be. Regardless, high levels of use of medications for chronic symptoms such as sleep disturbance and pain can create dependence, which may escalate both medical symptoms and medication use over time (Asmundson et al., 2000) .
| Summary
AS is associated with increased engagement in a range of maladaptive health behaviors, and this may be yet another way that AS exacerbates chronic medical conditions. Individuals with high AS are more likely to use recreational or illicit substances, engage in unhealthy eating, experience sleep disturbance, and rely on symptom-driven medical treatment possibly instead of using preventive medical care. Experiential avoidance seems to play a role in the AS-substance use and AS-unhealthy eating connections, whereas the association of AS with dysfunctional sleep and overuse of medical treatment appears to be more related to interoceptive sensitivity (i.e., greater sensitivity to internal sensations). Therefore, future studies on AS and maladaptive behaviors should take both experiential avoidance and interoceptive sensitivity into account to more thoroughly model how AS leads to increased engagement in unhealthy behaviors and, subsequently, to greater chronic illness. Further, longitudinal studies that model AS and other cognitive-affective and behavioral factors as predictors of chronic illness are necessary to clarify if AS does indeed increase risk of chronic illness by promoting maladaptive health behaviors.
| PATHOPHYSIOLOGICAL/ PATHOMECHANICAL ALTERATIONS
The final major way in which AS may exacerbate chronic medical conditions is by increasing risk of pathophysiological and pathomechanical alterations that increase vulnerability for chronic illness. AS amplifies stress reactivity, because individuals with high AS are more likely to perceive experiences as stressful due to their fear of the anxiety-related sensations that accompany stress reactivity (Reiss, 1991) . This includes physiological stress reactivity, specifically autonomic nervous system arousal (e.g., Busscher, Spinhoven, van Gerwen, & de Geus, 2013; Richards & Bertram, 2000) . Individuals with high AS initially experience normal physiological reactions to stress, such as increased heart and respiration rates, but they tend to perceive these normal physiological reactions as dangerous. Unfortunately, their appraisal of their own bodily responses as dangerous leads them to experience even more bodily sensations, creating a vicious cycle of physiological reactivity, fear, and anxiety (Reiss, 1991) . Although high AS individuals initially misperceive their bodily sensations as more dangerous than they really are, over time, experiencing chronic autonomic nervous system arousal may actually lead to more permanent pathophysiological changes that confer risk of chronic illness. In addition, one study suggests there may also be a link between AS and biomechanical changes over time (Kuznetsov et al., 2015) .
| High blood pressure
High blood pressure increases risk of many chronic medical conditions, particularly cardiovascular disease, and is associated with chronic autonomic nervous system arousal (Guyenet, 2006) , making it a pathophysiological factor of interest in the AS-chronic disease association. A few studies have connected AS to indicators of cardiovascular disease (e.g., Norman & Lang, 2005; Seldenrijk et al., 2013) , but to our knowledge, there are few studies on the association between AS and blood pressure. In a study of healthy adolescents (Akc ßa, A gac ß Vural, T€ urko glu, & Kılıc ß, 2014), AS was associated with higher diastolic blood pressure even when controlling for age, sex, and pubertal stage. Two other studies found that, compared to healthy controls, individuals with hypertension report higher levels of AS (Delle Chiaie et al., 2011; Pagotto, Fallo, Fava, Boscaro, & Sonino, 1992) . Akc ßa and colleagues conclude that the chronic autonomic nervous system arousal associated with AS may lead to elevations in blood pressure which may, in turn, increase risk of cardiovascular disease.
| Increased stress hormone levels
It has also been suggested that the chronic autonomic nervous system arousal associated with AS may lead to greater production of stress hormones (e.g., Seldenrijk et al., 2013) , which increase risk of chronic medical conditions (Lechin et al., 1994) . The most commonly examined stress hormone in relation to psychiatric symptoms is cortisol. Elevated cortisol is associated with depressive and anxiety disorders as well as chronic disease and is thought to be either a shared risk factor for mental and physical health conditions or a possible mediator of their association (e.g., Brown, Varghese, & McEwen, 2004) . However, the only published study we found does not support the hypothesis that AS intensifies risk of chronic medical conditions by increasing cortisol secretion. In the Netherlands Study on Depression and Anxiety (van Santen et al., 2011) , AS was unrelated to salivary cortisol levels in a large community sample of adults. Therefore, at this point, the AS-stress hormone hypothesis remains unsupported but merits further investigation given limited empirical testing to date.
| Decreased immune system functioning
Another way that AS may increase pathophysiological vulnerability for chronic illness is by decreasing immune system functioning. Cytokines are one type of protein that mediate immune system responding to injury and infection, and greater levels of proinflammatory cytokines in the body are indicative of decreased immune system functioning (Schiepers, Wichers, & Maes, 2005) . Many studies have associated proinflammatory cytokines with increased psychopathology, particularly major depressive disorder, and chronic illnesses, such as cardiovascular disease and cancer (for a review, see Schiepers et al., 2005) . To our knowledge, there are no published studies examining the association between AS and proinflammatory cytokines; however, there is a growing body of research demonstrating that proinflammatory cytokines may be elevated in individuals with anxiety disorders (e.g., von Kanel et al., 2007) .
The association of panic disorder with proinflammatory cytokines is particularly of note, given that AS is so closely associated with panic disorder. The limited studies examining cytokines in panic disorder have led to mixed findings. van Duinen et al. (2008) found no evidence of elevations in proinflammatory cytokines among individuals with panic disorder versus matched controls. In contrast, Hoge et al. (2009) found that individuals with panic disorder had higher levels of 16 of 20 measured cytokines than matched controls. It is unclear why these two studies yielded discrepant findings, and further research is needed to clarify if the evidence leans for or against a connection between panic disorder and proinflammatory cytokines. Still, the potential association between panic disorder and increased cytokine levels suggests that AS may be related to chronic inflammation and decreased immune functioning. Further studies including measures of AS are needed to draw more definitive conclusions.
The link between AS and immune system functioning may also be relevant to respiratory illnesses, such as asthma. For instance, Barone et al. (2008) found that AS was significantly higher among asthmatic individuals with atopic status compared to those without. Atopy refers to a condition associated with the presence of allergen-specific immunoglobulin E (IgE) antibodies, which can result in allergic symptoms in the nose, lungs, and throat. About 60% of individuals with asthma have atopic status (AllenRamey et al., 2005) , and there is some evidence to suggest that atopy is associated with the tendency to experience chronic anxiety (e.g., Hart, Lahey, Hynd, Loeber, & McBurnett, 1995) , in addition to its association with AS. However, the temporal relationship between AS and atopy is not yet clear, and more longitudinal research is needed to test these causal relationships.
| Change in postural control
Pathomechanical alterations, such as changes in postural control, may also be associated with AS and linked to increased vulnerability to chronic illness. Only one study that we know of has examined this association. Kuznetsov et al. (2015) found that, among individuals with asthma, high AS-physical concerns were associated with distinct postural control strategies, or methods for maintaining an upright body position while standing, that the authors hypothesize may contribute to deficits in postural control over time. The authors note that, over time, poor postural control strategies are associated with increased impairment in daily activities and increased risk of declines in motor functioning and injury. Patients with asthma and other chronic respiratory diseases have been shown to develop changes in posture and balance over time, due to an excessive recruitment of muscles used for respiration in response to airflow obstruction (e.g., Smith, Chang, Seale, Walsh, & Hodges, 2010) ; in turn, these changes are associated with disruptions in overall biomechanics (e.g., Brasiliense et al., 2011) . The finding that AS may be associated with these disruptions suggests it may also play an important role in biomechanical alterations associated with reduced engagement in daily activities and risk of injury in asthmatics. These disruptions may, in turn, lead to increased asthma symptoms or contribute to secondary medical problems (i.e., injury). There is limited empirical testing of this hypothesis to date, but the role of AS in biomechanical alterations merits further investigation.
| Summary
The connection between AS and pathophysiological and pathomechanical alterations underlying chronic illness remains largely speculative at this point, as only a limited number of studies have examined whether AS is associated with pathophysiological and biomechanical changes. There is some evidence that AS is associated with increased diastolic blood pressure and decreased postural control, and mixed evidence on its association with decreased immune functioning. Therefore, the relationships between AS and these alterations are in need of further study. It also remains unclear whether, if established, these relationships are causal such that AS-related chronic autonomic nervous system arousal causes these pathophysiological and biomechanical alterations. Longitudinal studies measuring AS, autonomic nervous system arousal, and pathophysiological and pathomechanical factors are needed to clarify the temporal sequencing of these potential risk factors for chronic medical conditions.
| CONCLUSIONS
In this paper, we have focused on the idea that AS may increase risk of chronic medical conditions. We have reviewed evidence that AS is associated with increased fear of medical condition-specific symptoms, avoidance of and interference with behaviors that promote physical well-being, and engagement in behaviors that are detrimental to physical health. We have also presented limited evidence, but promising theoretical rationale, that AS may also be associated with pathophysiological factors contributing to chronic illness. Theoretically, AS may exacerbate chronic illness by increasing these known risk factors for poor physical health, and experiencing chronic medical symptoms may intensify AS, maintaining a vicious cycle of AS and deteriorating physical health over time (see Figure 1) . However, inferences about causality cannot be drawn at this point, because most of the evidence of a connection between AS, health-related risk factors, and chronic illness comes from cross-sectional studies. Longitudinal investigations are sorely needed to improve upon current theoretical models of chronic illness.
Given our current, however limited, understanding of AShealth associations, there is still clear utility in assessing and treating AS. Simply administering the ASI-3 to patients who endorse chronic medical symptoms may help identify who is at risk of developing longer-term problems with chronic illness. Most individuals seek mental and physical health care from their primary care physicians and do not seek specialty mental health services (Gunn & Blount, 2009) , so it may be especially useful to incorporate assessments of AS into primary care visits. It also seems imperative to integrate mental and physical health care for patients with high AS. Because their psychological and medical symptoms are often interrelated, they may be best treated in tandem. For instance, if a patient with high AS is experiencing both panic and asthma attacks, successful treatment may hinge upon a psychologist and physician working together to identify the psychological and medical underpinnings of the attacks and treating the attacks as related phenomena. Establishing roles for mental health professionals within primary health-care teams will likely increase the quality of care delivered to patients, particularly those with high AS.
The study of behavioral treatments in the reduction of AS is well underway; for instance, aerobic exercise has been studied as both a stand-alone treatment (e.g., Broman-Fulks, Berman, Rabian, & Webster, 2004; Smits et al., 2008) and as a supplement to CBT (e.g., Sabourin, Watt, Krigolson, & Stewart, 2016; Watt, Stewart, Lefaivre, & Uman, 2006) , with promising effects after just a single 30-min session of exercise (Lebouthillier & Asmundson, 2015) . There is also research to suggest that AS mediates the association between AS and chronic medical conditions. AS may exacerbate chronic medical symptoms through four key pathways, which in turn may lead to the intensification of AS, maintaining this cycle over time aerobic exercise and decreased coping motivations for maladaptive behaviors, such as marijuana use (Smits, BonnMiller, Tart, Irons, & Zvolensky, 2011) . Continued investigation of reductions in AS as a mediator between exercise interventions and reductions of other maladaptive health behaviors will be important in further elucidating the contributory role of AS to these behavioral risk factors, as well as further highlighting the importance of recommending and facilitating behavioral interventions that can reduce AS and associated unhealthy behaviors. However, it is also important to keep in mind findings like those of Farris et al.' (2017) recent study, in which higher AS among physically inactive smokers was associated with greater perceived exertion during the initial stages of moderate-intensity exercise, as well as Farris, Davis, et al.' (2016) study in which AS was strongly negatively associated with exercise tolerance when exercise self-efficacy was also low. These findings suggest that individuals with AS may be at risk of early termination of physical activity and that, when recommending aerobic exercise to individuals with high AS, psychoeducation regarding AS and typical reactions to physical activity may be particularly important in order to reduce the risk of early termination of exercise.
Other interventions have shown utility in reducing AS that may also be important to recommend to patients. As is the case for aerobic exercise, interoceptive exposure may be the mechanism through which these interventions reduce AS; they include activities such as guided hyperventilation, spinning, straw breathing, and jumping jacks (e.g., Schmidt, Capron, Raines, & Allan, 2014; Short, Allan, Raines, & Schmidt, 2015) . Interventions utilizing interoceptive exposure have shown utility not only in reducing AS, but in simultaneously facilitating gains in health-related behaviors, including improvements in sleep (Short et al., 2015) , smoking cessation (Smits et al., 2016) , reduced heroin cravings (Tull, Schulzinger, Schmidt, Zvolensky, & Lejuez, 2007) , and increased HIV medication adherence (Brandt, Paulus, Garza, et al., 2017) . These findings further highlight the importance of interoceptive exposure interventions in reducing both AS and associated health behaviors and outcomes.
There are a number of areas that we believe will be particularly important in the future study of AS-health associations. First, longitudinal modeling of AS-health associations will expand our understanding of the ways in which AS interacts with the developmental course of physical illness; in particular, the ways in which it interacts with onset, maintenance, and relapse/recurrence processes. As it stands, we can primarily make inferences regarding the association between AS and the presence of medical conditions and associated health behaviors, rather than the impact of AS on the developmental or longitudinal course of illness.
Second, social determinants of health are vitally important issues to consider in any model of wellness and disease.
However, a vast majority of the studies on the association between AS and health fail to consider the role of socioeconomic position, subjective social status, access to care, transportation, financial strain, and racial/ethnic issues. In fact, many of the studies reviewed do not include any report of these variables, leaving many unanswered questions as to the role these variables might play in the current model of AS and chronic illness. However, there are studies indicating that sociodemographic variables may play an important moderating role in the association between AS and healthrelated variables, highlighting the importance of inclusion of these variables in future studies. For instance, one recent study found that race significantly moderated the association between AS and cannabis use, such that AS-physical concerns significantly predicted cannabis-related problems among black, but not white, individuals (Dean, Ecker, & Buckner, 2017) . In another study, AS mediated the association between race and differences in sleep duration among individuals with cardiovascular disease, such that being black (vs. white) was indirectly associated with decreased sleep duration through high AS (Alc antara, Cosenzo, Fan, Doyle, & Shaffer, 2017) . These studies point to the importance of considering sociodemographic variables in the model of AS-health associations.
Finally, research suggests some utility in alternative measurement approaches to AS, such as viewing it as a taxonic (e.g., with a dichotomous latent class structure), rather than dimensional (e.g., single latent continuous structure) construct (e.g., Bernstein, Zvolensky, Stewart, & Comeau, 2007; Schmidt, Kotov, Lerew, Joiner, & Ialongo, 2005) . If this were the case, it may be useful to evaluate AS-health associations from the perspective that there is a normative/low-risk form of AS, as well as a high-risk or vulnerability-conferring form. Further consideration of these structural issues and would likely contribute to our current understanding of which subset of individuals are at most risk of the development of adverse health outcomes, as well as how we can best identify those at-risk individuals.
